Cited 0 times in Scipus Cited Count

Rational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction

DC Field Value Language
dc.contributor.authorShah, M-
dc.contributor.authorShin, JY-
dc.contributor.authorWoo, HG-
dc.date.accessioned2023-06-14T02:52:33Z-
dc.date.available2023-06-14T02:52:33Z-
dc.date.issued2023-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/25953-
dc.description.abstractSince the emergence of SARS-CoV-2, dozens of variants of interest and half a dozen variants of concern (VOCs) have been documented by the World Health Organization. The emergence of these VOCs due to the continuous evolution of the virus is a major concern for COVID-19 therapeutic antibodies and vaccines because they are designed to target prototype/previous strains and lose effectiveness against new VOCs. Therefore, there is a need for time- and cost-effective strategies to estimate the immune escape and redirect therapeutic antibodies against newly emerging variants. Here, we computationally predicted the neutralization escape of the SARS-CoV-2 Delta and Omicron variants against the mutational space of RBD-mAbs interfaces. Leveraging knowledge of the existing RBD-mAb interfaces and mutational space, we fine-tuned and redirected CT-p59 (Regdanvimab) and Etesevimab against the escaped variants through complementarity-determining regions (CDRs) diversification. We identified antibodies against the Omicron lineage BA.1 and BA.2 and Delta variants with comparable or better binding affinities to that of prototype Spike. This suggests that CDRs diversification by hotspot grafting, given an existing insight into the Ag-Abs interface, is an exquisite strategy to redirect antibodies against preselected epitopes and combat the neutralization escape of emerging SARS-CoV-2 variants.-
dc.language.isoen-
dc.subject.MESHAntibodies, Monoclonal-
dc.subject.MESHComplementarity Determining Regions-
dc.subject.MESHCOVID-19-
dc.subject.MESHHumans-
dc.subject.MESHSARS-CoV-2-
dc.titleRational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction-
dc.typeArticle-
dc.identifier.pmid37063859-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102385-
dc.subject.keywordantibody-
dc.subject.keywordCDR diversification-
dc.subject.keywordimmune escape-
dc.subject.keywordomicron-
dc.subject.keywordOmicron (B.1.1.529)-
dc.subject.keywordSARS-CoV-2-
dc.contributor.affiliatedAuthorShah, M-
dc.contributor.affiliatedAuthorWoo, HG-
dc.type.localJournal Papers-
dc.identifier.doi10.3389/fimmu.2023.1113175-
dc.citation.titleFrontiers in immunology-
dc.citation.volume14-
dc.citation.date2023-
dc.citation.startPage1113175-
dc.citation.endPage1113175-
dc.identifier.bibliographicCitationFrontiers in immunology, 14. : 1113175-1113175, 2023-
dc.identifier.eissn1664-3224-
dc.relation.journalidJ016643224-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Physiology
Files in This Item:
37063859.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse